Biosimilars Market Expected To Be Worth $41.7 Billion By 2024

Biosimilars costly

The global biosimilars market is expected to reach a whopping $41.7 billion by 2024, with significant growth coming from 2016-2024. The assessment comes from data published in a GrandViewResearch.com report. The biggest factor leading to the explosive biosimilars growth is that a number of major biologic drugs are set to lose patent protection.

Read the source article at Pharmacy Choice

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>